{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T23:59:15Z","timestamp":1767830355372,"version":"3.49.0"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:sec>\n            <jats:title>Purpose<\/jats:title>\n            <jats:p>The incidence of lung cancer has increased steadily. We meta-analyzed to assess the impact of <jats:sup>18<\/jats:sup>F-FDG PET on the management of lung cancer to detect recurrence\/metastasis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Materials and Methods<\/jats:title>\n            <jats:p>We performed systematic searches of Medline and Embase databases for English-language publications. All published studies regarding the impact of PET on the management of patients with lung cancer in detection of recurrence\/metastasis were searched. The proportion of management change (%) defined as the percentage of patients who changed management after FDG PET to patients who had FDG PET was calculated. The data from each study were analyzed using MedCalc Statistical Software version 14.12.0 (MedCalc Software, Ostend, Belgium).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Eight studies including 523 patients were eligible for inclusion in the study. The impact of <jats:sup>18<\/jats:sup>F-FDG PET for the purpose of detecting recurrence\/metastasis in patients with lung cancer was evaluated using management change rates, which were ranged from 28.6% to 79.2% with a pooled effect of 61.4% (95% confidence interval, 49.5%\u201372.7%; <jats:italic toggle=\"yes\">I<\/jats:italic>\n                                 <jats:sup>2<\/jats:sup> = 85.7%). In a subgroup analysis, impact of <jats:sup>18<\/jats:sup>F-FDG PET was evaluated in studies of patients with non\u2013small cell lung cancer with indication of abnormal findings of conventional imaging, elevated tumor markers, and clinical symptoms with the pooled rate of management change of 62.2% (95% confidence interval, 44.2%\u201378.5%; <jats:italic toggle=\"yes\">I<\/jats:italic>\n                                 <jats:sup>2<\/jats:sup> = 88.0%).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>We have highlighted that <jats:sup>18<\/jats:sup>F-FDG PET has a major impact on the management of patients with recurrent lung cancer. These findings suggest that <jats:sup>18<\/jats:sup>F-FDG PET should be performed in patients with lung cancer, especially in cases involving equivocal or suspicious recurrence\/metastasis on conventional imaging, elevated tumor markers, or clinical symptoms during follow-up.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/rlu.0000000000003880","type":"journal-article","created":{"date-parts":[[2021,9,10]],"date-time":"2021-09-10T22:11:33Z","timestamp":1631311893000},"page":"983-988","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Impact of Follow-up 18F-FDG PET on the Management in Patients With Lung Cancer"],"prefix":"10.1097","volume":"46","author":[{"given":"Hai-Jeon","family":"Yoon","sequence":"first","affiliation":[{"name":"Department of Nuclear Medicine, Ewha Womans University College of Medicine, Seoul"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyoungjune","family":"Pak","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine and Biomedical Research Institute, Pusan National University Hospital, Busan, Republic of Korea."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,8,26]]},"reference":[{"key":"bib1-20250621","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21590","article-title":"Cancer statistics, 2020","volume":"70","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"bib2-20250621","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1148\/rg.2018170081","article-title":"Revisions to the TNM staging of lung cancer: rationale, significance, and clinical application","volume":"38","year":"2018","journal-title":"Radiographics"},{"key":"bib3-20250621","first-page":"28S","article-title":"Early detection of cancer recurrence: 18F-FDG PET\/CT can make a difference in diagnosis and patient care","volume":"48","year":"2007","journal-title":"J Nucl Med"},{"key":"bib4-20250621","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.2214\/AJR.19.21227","article-title":"Lung cancer recurrence: 18F-FDG PET\/CT in clinical practice","volume":"213","year":"2019","journal-title":"AJR Am J Roentgenol"},{"key":"bib5-20250621","article-title":"Lung cancer prognosis before and after recurrence in a population-based setting","volume":"107","year":"2015","journal-title":"J Natl Cancer Inst"},{"key":"bib6-20250621","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.6004\/jnccn.2019.0059","article-title":"NCCN guidelines insights: non\u2013small cell lung cancer, version 1.2020","volume":"17","year":"2019","journal-title":"J Natl Compr Canc Netw"},{"key":"bib7-20250621","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jtcvs.2012.05.059","article-title":"Development of the American Association for Thoracic Surgery guidelines for low-dose computed tomography scans to screen for lung cancer in North America: recommendations of the American Association for Thoracic Surgery Task Force for Lung Cancer Screening and Surveillance","volume":"144","year":"2012","journal-title":"J Thorac Cardiovasc Surg"},{"key":"bib8-20250621","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3390\/diagnostics6040036","article-title":"The role of PET\/CT molecular imaging in the diagnosis of recurrence and surveillance of patients treated for non-small cell lung cancer","volume":"6","year":"2016","journal-title":"Diagnostics"},{"key":"bib9-20250621","first-page":"311","article-title":"Diagnosis of recurrence and follow-up using FDG-PET\/CT for postoperative non-small-cell lung cancer patients","volume":"69","year":"2020","journal-title":"Gen Thorac Cardiovasc Surg"},{"key":"bib10-20250621","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1177\/0284185113498536","article-title":"Diagnostic efficacy of PET and PET\/CT for recurrent lung cancer: a meta-analysis","volume":"55","year":"2014","journal-title":"Acta Radiol"},{"key":"bib11-20250621","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1214\/aoms\/1177729756","article-title":"Transformations related to the angular and the square root","volume":"21","year":"1950","journal-title":"Ann Math Stat"},{"key":"bib12-20250621","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","year":"1986","journal-title":"Control Clin Trials"},{"key":"bib13-20250621","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","year":"2003","journal-title":"BMJ"},{"key":"bib14-20250621","doi-asserted-by":"crossref","first-page":"296","DOI":"10.5455\/aim.2016.24.296-298","article-title":"Value of positron emission tomography\/computed tomography (PET-CT) in suspected non-small cell lung cancer recurrence and impact on patient management","volume":"24","year":"2016","journal-title":"Acta Informatica Medica"},{"key":"bib15-20250621","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/01.coc.0000054889.58718.6F","article-title":"Impact of positron emission tomography on the management of patients with small-cell lung cancer: preliminary experience","volume":"27","year":"2004","journal-title":"Am J Clin Oncol"},{"key":"bib16-20250621","first-page":"1605","article-title":"The utility of (18)F-FDG PET for suspected recurrent non-small cell lung cancer after potentially curative therapy: impact on management and prognostic stratification","volume":"42","year":"2001","journal-title":"J Nucl Med"},{"key":"bib17-20250621","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.lungcan.2013.03.015","article-title":"Diagnosis of recurrence and assessment of post-recurrence survival in patients with extracranial non-small cell lung cancer evaluated by 18F-FDG PET\/CT","volume":"81","year":"2013","journal-title":"Lung Cancer"},{"key":"bib18-20250621","first-page":"1640","article-title":"PET\/CT using 18F-FDG in suspected lung cancer recurrence: diagnostic value and impact on patient management","volume":"45","year":"2004","journal-title":"J Nucl Med"},{"key":"bib19-20250621","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s12149-015-0963-9","article-title":"Impact of FDG-PET findings on decisions regarding patient management strategies: a multicenter trial in patients with lung cancer and other types of cancer","volume":"29","year":"2015","journal-title":"Ann Nucl Med"},{"key":"bib20-20250621","doi-asserted-by":"crossref","first-page":"855","DOI":"10.2967\/jnumed.115.165480","article-title":"18F-FDG PET\/CT: therapy response assessment interpretation (Hopkins criteria) and survival outcomes in lung cancer patients","volume":"57","year":"2016","journal-title":"J Nucl Med"},{"key":"bib21-20250621","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1038\/bjc.2015.151","article-title":"(18)F-fluorodeoxyglucose positron-emission tomography-computed tomography to diagnose recurrent cancer","volume":"112","year":"2015","journal-title":"Br J Cancer"},{"key":"bib22-20250621","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1510\/icvts.2009.227538","article-title":"Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients","volume":"10","year":"2010","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"bib23-20250621","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.ejrad.2009.03.007","article-title":"Integrated FDG-PET\/CT vs. standard radiological examinations: comparison of capability for assessment of postoperative recurrence in non-small cell lung cancer patients","volume":"74","year":"2010","journal-title":"Eur J Radiol"},{"key":"bib24-20250621","doi-asserted-by":"crossref","first-page":"879","DOI":"10.7326\/0003-4819-139-11-200311180-00013","article-title":"Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non\u2013small-cell lung cancer: a meta-analysis","volume":"139","year":"2003","journal-title":"Ann Intern Med"},{"key":"bib26-20250621","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1093\/icvts\/ivs368","article-title":"18F-fluorodeoxyglucose positron emission tomography\/computed tomography is useful in postoperative follow-up of asymptomatic non-small-cell lung cancer patients","volume":"15","year":"2012","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"bib27-20250621","doi-asserted-by":"crossref","first-page":"831","DOI":"10.2967\/jnumed.112.103911","article-title":"Impact of 18F-FDG PET used after initial treatment of cancer: comparison of the National Oncologic PET registry 2006 and 2009 cohorts","volume":"53","year":"2012","journal-title":"J Nucl Med"}],"updated-by":[{"DOI":"10.1097\/rlu.0000000000004709","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000}}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000003880","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T20:04:46Z","timestamp":1750536286000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000003880"}},"subtitle":["A Meta-analysis"],"short-title":[],"issued":{"date-parts":[[2021,8,26]]},"references-count":26,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000003880","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8,26]]}}}